|
A hormone
produced by the kidneys may eventually be helpful in the treatment
of Alzheimer's disease and other neurodegenerative conditions,
according to researchers at the Burnham Institute in La Jolla,
California.
The hormone,
called erythropoietin (EPO), boosts the production of red blood
cells and can also protect nerve cells in the brain from injury
or death, said the study published in Nature. EPO is used in the
treatment of anemia and some athletes claim it boosts the oxygen-carrying
capacity of the blood, improving performance.
EPO is also
produced in the brain after it has been injured from free radicals,
and researchers speculate that it may prevent the death of nerve
cells as a result. Tissue damage caused by low oxygen levels,
inflammation and diseases causing deterioration of brain function
can lead to the development of free radicals.
Researchers
treated rat brain cells with EPO and found it prevented the cell
death that would have occurred with treatments that cause too
many free radicals to be released. Researchers also defined the
way that EPO prevents nerve cell damage in the brain, saying it
triggers a complex series of signals transmitted in the cell.
The study
is very encouraging, said the researchers, as they have found
the pathway to nerve cell protection using a known drug that is
already used for other indications with a good record of safety.
Other
sources: Nature
|